Accepted answer
4 ÷ 1.5 = 2.67 mg/mL. Concentration is vial content divided by diluent volume, so 4 mg of peptide in 1.5 mL of phosphate-buffered diluent gives 2.67 mg/mL. On a U-100 barrel one unit is 0.01 mL, so one unit of this solution carries 0.027 mg — 26.67 µg. That is the number to write on the label, because you will not reconstruct it from memory at an awkward moment.
Concretely, this is not exotic. It is just the difference between doing it deliberately and doing it approximately.
Tilting the vial to pool solution in the corner before the final draw, and giving it a minute to drain down the walls, genuinely recovers ten to twenty microlitres.
Dead space by syringe type
| Configuration | Dead volume | Loss at 5 mg/mL | Over 20 draws |
|---|
| Fixed-needle insulin syringe | 3–5 µL | 15–25 µg | 0.3–0.5 mg |
| Low-dead-space, detachable | <2 µL | <10 µg | <0.2 mg |
| Standard luer-lock + 30G | 35–60 µL | 175–300 µg | 3.5–6 mg |
| Luer-lock + 21G drawing needle | 70–100 µL | 350–500 µg | 7–10 mg |
Do not use the same needle to pierce the stopper and to administer.
The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.